4.1 Article

Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI)

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide

Adriana Herrera et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Cardiac & Cardiovascular Systems

Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review

Matthew R. Timlin et al.

PEDIATRIC CARDIOLOGY (2017)

Article Endocrinology & Metabolism

Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders

Charles A. Stanley

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Medicine, Research & Experimental

The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance

Motoyuki Tamaki et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Medical Laboratory Technology

Hyperinsulinism in infancy and childhood: When an insulin level is not always enough

Andrew A. Palladino et al.

CLINICAL CHEMISTRY (2008)

Article Endocrinology & Metabolism

Neonates with symptomatic hyperinsulinemic hypoglycemia generate inappropriately low serum cortisol counterregulatory hormonal responses

K Hussain et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)